Data from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL

MLA

Arun P. Wiita, et al. Data from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL. Apr. 2023. EBSCOhost, https://doi.org/10.1158/2159-8290.c.6548995.v1.

APA

Arun P. Wiita, Elliot Stieglitz, Aashish Manglik, Ansuman T. Satpathy, Byron C. Hann, Faranak Fattahi, Veronica Steri, Paul Phojanokong, Anne Deucher, Jonathan Ramirez, Kevin R. Parker, Sagar P. Bapat, Jeffrey D. Whitman, Kristie L. White, Makeba Marcoulis, Jose M. Rivera, Yu-Hsiu T. Lin, Neha Paranjape, Huimin Geng, … Matthew A. Nix. (2023). Data from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL. https://doi.org/10.1158/2159-8290.c.6548995.v1

Chicago

Arun P. Wiita, Elliot Stieglitz, Aashish Manglik, Ansuman T. Satpathy, Byron C. Hann, Faranak Fattahi, Veronica Steri, et al. 2023. “Data from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL,” April. doi:10.1158/2159-8290.c.6548995.v1.